n,n-dimethylarginine has been researched along with Brain Ischemia in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 11 (91.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appel, D; Böger, RH; Czorlich, P; Goetz, AE; Hannemann, J; Schwedhelm, E; Seeberger, M | 1 |
| Abusoglu, S; Akbulut, D; Bal, C; Celik, HT; Ercan, M; Güzel, I; Mungan, S; Oguz, EF; Yilmaz, FM | 1 |
| Atzler, D; Böger, RH; Choe, CU; Cordts, K; Gerloff, C; Grant, PJ; Grzybowski, R; Hornig, S; Lezius, S; Lüneburg, N; Magnus, T; Neu, A; Schwedhelm, E; Thomalla, G | 1 |
| Chen, S; Deb-Chatterji, M; Dong, Q; Kielstein, JT; Li, N; Weissenborn, K; Worthmann, H | 1 |
| Li, X; Ma, JP; Wang, JZ; Wang, L; Wu, CJ; Xia, XS | 1 |
| Brouns, R; De Deyn, PP; Marescau, B; Possemiers, I; Sheorajpanday, R | 1 |
| Abe, A; Katayama, Y; Katsura, K; Nagayama, H; Nishiyama, Y; Otsuka, T; Ueda, M | 2 |
| Christopher, R; Mamatha, SN; Nagaraja, D; Philip, M | 1 |
| Böger, RH; Lüneburg, N; Maas, R; Schwedhelm, E; Töpper, RF; von Holten, RA | 1 |
| Wang, DH; Wu, YH; Zhang, X | 1 |
| Jung, CS; Lange, B; Seifert, V; Zimmermann, M | 1 |
1 review(s) available for n,n-dimethylarginine and Brain Ischemia
| Article | Year |
|---|---|
Asymmetric dimethyarginine as marker and mediator in ischemic stroke.
Topics: Animals; Arginine; Biomarkers; Brain Ischemia; Cerebrovascular Circulation; Enzyme Inhibitors; Humans; Methylation; Nitric Oxide Synthase; Oxidative Stress; Protein Processing, Post-Translational; Stroke | 2012 |
2 trial(s) available for n,n-dimethylarginine and Brain Ischemia
| Article | Year |
|---|---|
Supplementation of folic acid and vitamin B₁₂ reduces plasma levels of asymmetric dimethylarginine in patients with acute ischemic stroke.
Topics: Aged; Arginine; Blood Chemical Analysis; Brain Ischemia; Dietary Supplements; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Stroke; Time Factors; Treatment Outcome; Vitamin B 12 | 2014 |
Statin treatment decreased serum asymmetric dimethylarginine (ADMA) levels in ischemic stroke patients.
Topics: Aged; Aged, 80 and over; Arginine; Atherosclerosis; Atorvastatin; Brain Ischemia; Cholesterol, LDL; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Linear Models; Male; Middle Aged; Pravastatin; Prospective Studies; Pyrroles; Quinolines; Stroke | 2011 |
9 other study(ies) available for n,n-dimethylarginine and Brain Ischemia
| Article | Year |
|---|---|
Asymmetric and Symmetric Dimethylarginines are Markers of Delayed Cerebral Ischemia and Neurological Outcome in Patients with Subarachnoid Hemorrhage.
Topics: Adult; Aged; Arginine; Biomarkers; Brain Ischemia; Cerebral Angiography; Female; Humans; Incidence; Male; Middle Aged; Outcome Assessment, Health Care; Subarachnoid Hemorrhage | 2018 |
Serum asymmetric dimethylarginine and nitric oxide levels in Turkish patients with acute ischemic stroke.
Topics: Aged; Aged, 80 and over; Arginine; Brain Ischemia; Female; Humans; Male; Middle Aged; Nitric Oxide; Stroke | 2019 |
Guanidino compound ratios are associated with stroke etiology, internal carotid artery stenosis and CHA
Topics: Aged; Arginine; Biomarkers; Brain Ischemia; Carotid Arteries; Carotid Stenosis; Cross-Sectional Studies; Female; Homoarginine; Humans; Intracranial Hemorrhages; Male; Middle Aged; Recurrence; Stroke | 2019 |
Dimethylarginine levels in cerebrospinal fluid of hyperacute ischemic stroke patients are associated with stroke severity.
Topics: Aged; Arginine; Brain Ischemia; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Stroke | 2009 |
Asymmetric dimethylarginine (ADMA) as a possible risk marker for ischemic stroke.
Topics: Age Factors; Aged; Arginine; Biomarkers; Blood Glucose; Brain Ischemia; Cholesterol, LDL; Dyslipidemias; Female; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Predictive Value of Tests; Risk Factors; Sensitivity and Specificity; Stroke; Up-Regulation | 2010 |
Asymmetric dimethylarginine as a risk marker for early-onset ischemic stroke in Indian population.
Topics: Adolescent; Adult; Analysis of Variance; Arginine; Biomarkers; Brain Ischemia; Case-Control Studies; Female; Humans; India; Linear Models; Male; Middle Aged; Risk; Stroke; Time Factors; Young Adult | 2011 |
Symmetric dimethylarginine is a marker of detrimental outcome in the acute phase after ischaemic stroke: role of renal function.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Brain Ischemia; Chromatography, Liquid; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Kidney; Male; Middle Aged; Multivariate Analysis; Outcome Assessment, Health Care; Prognosis; Proportional Hazards Models; Stroke; Tandem Mass Spectrometry; Time Factors | 2012 |
Role of asymmetric dimethylarginine in acute lung injury induced by cerebral ischemia/reperfusion injury in rats.
Topics: Acute Lung Injury; Animals; Arginine; Brain Ischemia; Male; Myosin-Light-Chain Kinase; Nitric Oxide Synthase; Protein Kinase C; Rats; Rats, Sprague-Dawley; Reperfusion Injury; RNA, Messenger; Up-Regulation | 2011 |
The CSF concentration of ADMA, but not of ET-1, is correlated with the occurrence and severity of cerebral vasospasm after subarachnoid hemorrhage.
Topics: Adult; Arginine; Brain Ischemia; Endothelin-1; Female; Humans; Male; Middle Aged; Nitric Oxide; Retrospective Studies; Severity of Illness Index; Subarachnoid Hemorrhage; Vasodilation; Vasospasm, Intracranial | 2012 |